Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huatan Qushi Huoxue is a Traditional Chinese Medicine (TCM) herbal formula developed by The First Affiliated Hospital of Henan University of Chinese Medicine. Formulated as an oral granule, it is specifically designed for the treatment of non-alcoholic steatohepatitis (NASH) in obese patients. The formula's name reflects its core therapeutic principles in TCM: *Huatan* (resolving phlegm), *Qushi* (dispelling dampness), and *Huoxue* (promoting blood circulation). These actions are intended to address the underlying metabolic imbalances and pathological patterns associated with hepatic steatosis and obesity. It is currently being evaluated in randomized controlled trials to provide high-level evidence for its clinical efficacy in improving liver fat content and metabolic parameters.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huatan Qushi Huoxue.